These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate. Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198 [TBL] [Abstract][Full Text] [Related]
7. Pulmonary T cells induced by respiratory syncytial virus are functional and can make an important contribution to long-lived protective immunity. Ostler T; Ehl S Eur J Immunol; 2002 Sep; 32(9):2562-9. PubMed ID: 12207340 [TBL] [Abstract][Full Text] [Related]
8. Identifying targets in the hunt for effective respiratory syncytial virus interventions. Tayyari F; Hegele RG Expert Rev Respir Med; 2012 Apr; 6(2):215-22. PubMed ID: 22455493 [TBL] [Abstract][Full Text] [Related]
9. Functional disorder of primary immunity responding to respiratory syncytial virus infection in offspring mice exposed to a flame retardant, decabrominated diphenyl ether, perinatally. Watanabe W; Shimizu T; Sawamura R; Hino A; Konno K; Kurokawa M J Med Virol; 2010 May; 82(6):1075-82. PubMed ID: 20419825 [TBL] [Abstract][Full Text] [Related]
11. Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques. Elliott MB; Chen T; Terio NB; Chong SY; Abdullah R; Luckay A; Egan MA; Boutilier LA; Melville K; Lerch RA; Long D; Eldridge JH; Parks CL; Udem SA; Hancock GE Vaccine; 2007 Oct; 25(41):7132-44. PubMed ID: 17850933 [TBL] [Abstract][Full Text] [Related]
12. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice. Fu Y; He J; Zheng X; Wu Q; Zhang M; Wang X; Wang Y; Xie C; Tang Q; Wei W; Wang M; Song J; Qu J; Zhang Y; Wang X; Hong T Biochem Biophys Res Commun; 2009 Apr; 381(4):528-32. PubMed ID: 19233131 [TBL] [Abstract][Full Text] [Related]
13. Respiratory syncytial virus disease mechanisms implicated by human, animal model, and in vitro data facilitate vaccine strategies and new therapeutics. Moore ML; Peebles RS Pharmacol Ther; 2006 Nov; 112(2):405-24. PubMed ID: 16820210 [TBL] [Abstract][Full Text] [Related]
14. Impairment of T cell immunity by the respiratory syncytial virus: targeting virulence mechanisms for therapy and prophylaxis. González PA; Bueno SM; Riedel CA; Kalergis AM Curr Med Chem; 2009; 16(34):4609-25. PubMed ID: 19903147 [TBL] [Abstract][Full Text] [Related]
16. Polylactide-co-glycolide (PLG) microparticles modify the immune response to DNA vaccination. Helson R; Olszewska W; Singh M; Megede JZ; Melero JA; O'Hagan D; Openshaw PJ Vaccine; 2008 Feb; 26(6):753-61. PubMed ID: 18191308 [TBL] [Abstract][Full Text] [Related]
17. Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection. Kim S; Jang JE; Yu JR; Chang J Vaccine; 2010 May; 28(22):3801-8. PubMed ID: 20362203 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of illness during respiratory syncytial virus infection: the lungs, the virus and the immune response. Hoffman SJ; Laham FR; Polack FP Microbes Infect; 2004 Jul; 6(8):767-72. PubMed ID: 15207824 [TBL] [Abstract][Full Text] [Related]
19. Upregulation of TLR7 and TLR3 gene expression in the lung of respiratory syncytial virus infected mice. Huang S; Wei W; Yun Y Wei Sheng Wu Xue Bao; 2009 Feb; 49(2):239-45. PubMed ID: 19445181 [TBL] [Abstract][Full Text] [Related]
20. In Hot Pursuit of the First Vaccine Against Respiratory Syncytial Virus. Kim JY; Chang J Yonsei Med J; 2016 Jul; 57(4):809-16. PubMed ID: 27189271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]